CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Files An 8-K Entry into a Material Definitive Agreement

0

CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Files An 8-K Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement.

The descriptions of the Third Amendment to Executive Employment
Agreement set forth in Item 5.02 of this Report on Form 8-K are
incorporated by reference into this Item 1.01.
Item 5.02 Compensatory Arrangements of Certain Officers.
Effective March 31, 2017, the Company entered into a Third
Amendment to Executive Employment Agreement (the Third Amendment)
with Stephen Morgan (the Employee), amending his original, April
1, 2015 employment agreement, which was previously filed on March
31, 2015.The Third Amendment provides that the last day of the
term of Employees employment is extended from March 31, 2017, to
March 31, 2018, subject to the other terms and conditions of
Section 2 of the original agreement; provided, however, that (i)
the Company may change Employees status from full-time to
part-time employee at any time, (ii) concurrently with any such
change in status, the Company may modify Employees base
compensation amount and structure, and Employees prospective
bonus, if any, and (iii) notwithstanding any such change in
status, Employee shall remain eligible to receive the amount and
other benefits set forth in Section 5(f) in accordance with the
terms and conditions thereof.
The foregoing discussion of the Third Amendment is qualified in
its entirety by reference to the full text of the Third
Amendment. A copy of the Third Amendment is attached to this
Current Report on Form 8-K as Exhibit 10.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following Exhibits are furnished herewith:
Exhibit No.
Description
10.1
Third Amendment to Executive Employment Agreement


About CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI)

Cord Blood America, Inc. (CBAI), through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. CBAI’s subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. CBAI and its subsidiaries engage in the various business activities, such as CBAI and Cord specialize in providing private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord’s operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.

CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Recent Trading Information

CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) closed its last trading session up +0.00024 at 0.00284 with shares trading hands.